Press Kit
For interview requests, review copies, or expert commentary, contact the media team directly using the information at the bottom of this page.
All assets on this page are cleared for editorial use.
media@legacy-dna.com
Media contact & assets
For interview requests, review copies, expert commentary, and all media inquiries.
We respond to time-sensitive inquiries — including same-day requests for expert commentary — within 24 hours on business days.
Name: Wendy Bacigalupi
Email: media@legacy-dna.com
Phone: (407) 603-5403
For speaking and event inquiries: growth@legacy-dna.com
Download high-resolution images for editorial use
Please do not alter or apply filters to the headshot without prior approval.
Author: Dr. Roxie Mooney, DBA
Book summary & positioning
-
Dr. Roxie Mooney, DBA is the Founder and CEO of Legacy DNA and the author of Winning in Healthcare: How the Best Builders Turn Growth Into Enterprise Value. With more than 20 years in healthcare and four successful exits, she helps PE-backed and mid-market healthcare companies build commercialization systems that translate growth into durable enterprise value.
-
Dr. Roxie Mooney, DBA is the Founder and CEO of Legacy DNA, a healthcare commercialization and growth firm built for PE-backed and mid-market healthcare companies. She is the author of two books, Winning in Healthcare: How the Best Builders Turn Growth Into Enterprise Value and How Health Innovators Maximize Market Success, and she is the creator of the Enterprise Value Creation System™ (EVCS), a strategic framework that maps the six stages where scaling healthcare companies either compound value or quietly lose it long before diligence begins.
With more than 20 years of experience across healthcare, pharmacy, and health technology, Dr. Roxie has supported more than 100 healthcare launches and contributed to four successful exits, including helping BioPlus Specialty Pharmacy scale to nearly $2 billion before its acquisition by a Fortune 20 health plan.
-
Dr. Roxie Mooney, DBA is the Founder and CEO of Legacy DNA, where she partners with healthcare CEOs, operators, and private equity leaders to build commercialization systems that translate growth into durable enterprise value.
Her firm works at the intersection of commercialization, strategic alignment, and enterprise value creation — helping PE-backed and mid-market healthcare companies navigate the critical transition from growth to scalable, buyer-ready businesses that hold under pressure.
Dr. Roxie is the author of Winning in Healthcare: How the Best Builders Turn Growth Into Enterprise Value and the creator of the Enterprise Value Creation System™ — a proprietary framework that maps the six stages where healthcare companies either compound value or quietly lose it long before diligence begins. She is also the author of How Health Innovators Maximize Market Success (2019).
With more than 20 years across healthcare, pharmacy, and health technology, Dr. Roxie has worked inside some of the industry's most complex and high-growth environments. Her work includes helping BioPlus Specialty Pharmacy scale from approximately $750 million to nearly $2 billion, leading to an acquisition by a Fortune 20 health plan. She has supported more than 100 healthcare launches and contributed to four successful exits.
She is also the host of The Health Innovators Show, where she interviews founders, operators, and healthcare leaders shaping the future of healthcare innovation, growth, and enterprise value.
Eleven real healthcare growth stories. Six stages where value is won or lost. One system that connects them all.
Winning in Healthcare: How the Best Builders Turn Growth Into Enterprise Value is for healthcare leaders navigating the difficult transition from growth to durable enterprise value. Written by Legacy DNA founder Dr. Roxie Mooney, the book reveals the six stages where scaling healthcare companies either compound value or quietly lose it long before diligence begins. Through eleven real healthcare growth stories, it shows how the best builders create organizations that buyers trust, understand, and ultimately want to own.
Author Bios
Use the version that fits your format.
Book Info
Title: Winning in Healthcare: How the Best Builders Turn Growth Into Enterprise Value
Author: Dr. Roxie Mooney, DBA
Publisher: Legacy DNA Press
Pub. Date: 7/8/2026
Formats: Hardcover, Paperback, eBook
ISBN: 979-8-9959567-0-9 (hardcover)
Category: Healthcare Leadership / Business Strategy / Private Equity
Pitch angles
Most PE-backed healthcare companies hit the same wall: strong revenue, strong team, credible market — but the growth story doesn't hold when buyers look closely. The problem isn't performance. It's that the commercial system was never built to translate what the company is doing into what a buyer can verify, trust, and pay for.
Dr. Roxie Mooney has spent 20 years building those systems from the inside, and Winning in Healthcare is the first book to map exactly where the breakdown happens.
Mid-market healthcare is full of companies that are genuinely growing and genuinely at risk of leaving significant enterprise value on the table. The issue isn't effort or market opportunity — it's alignment: between strategy and execution, between what the company believes about itself and what buyers will conclude under scrutiny.
Dr. Roxie Mooney's new book traces eleven real healthcare growth stories to show what building with alignment actually looks like — and what it costs when it's missing.
Dr. Roxie Mooney spent 20 years doing work that most people in her field were unwilling to do: operating inside healthcare companies at their most difficult inflection points, helping them build the commercial infrastructure that holds under pressure.
The Enterprise Value Creation System™ is the product of that work — a proprietary framework built from real execution, not theory. Winning in Healthcare is the first time it's fully documented in a single place.
Dr. Roxie can address any of these directly or use them as a launching point for a deeper conversation.
You've spent 20 years inside healthcare companies at high-pressure moments. What's the pattern that most leaders don't see until it's too late?
The book is built around the Enterprise Value Creation System™. Can you walk us through the six stages and what makes the system different from standard growth strategy?
You talk about the difference between companies that grow and companies that build something that holds. What separates those two outcomes?
The book features 11 real healthcare leaders — people like Mark Montgomery at BioPlus and Malinka Walaliyadde at AKASA. What made you structure it around real stories rather than a framework presentation?
You describe the Value Gap as the place where most enterprise value is lost. Can you explain that concept and what it actually looks like inside a business?
What do buyers actually evaluate when they look at a healthcare company, and how is that different from what most sellers think they're evaluating?
You have a strong point of view that the exit is won long before the process begins. What does that mean practically for a CEO who is 18 months out from a transaction?
You've been part of four successful exits, including helping scale BioPlus from $750M to $2B. What's the moment in those processes that most people don't prepare for?
Legacy DNA is described as "not a marketing agency" and "not a fractional CMO service." How would you describe what you actually do? Why does that distinction matter to the clients you work with?
What's the most common thing you see healthcare CEOs getting wrong right now — and what would you tell them to do differently?